These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1017536)

  • 21. [Lipid distribution in the adult population of Catalonia].
    Plans P; Ruigómez J; Pardell H; Salleras L
    Rev Clin Esp; 1993 Jun; 193(1):35-42. PubMed ID: 8337460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [One year fenofibrate treatment of type II primary hyperlipidaemia. Effects on lipoproteins and biological tolerance (author's transl)].
    Drouin P; Méjean L; Lambert D; Wülfert E; Debry G
    Nouv Presse Med; 1980 Dec; 9(49):3753-7. PubMed ID: 7208342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hyperlipoproteinemias and their treatment on the peripheral circulation.
    Zelis R; Mason DT; Braunwald E; Levy RI
    J Clin Invest; 1970 May; 49(5):1007-15. PubMed ID: 5441536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies in asymptomatic primary hyperlipidaemia, III. Physical working capacity.
    Ekelund LG; Olsson AG
    Acta Med Scand; 1975 Jun; 197(6):487-94. PubMed ID: 1155224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of dyslipidemia in open population of Tiumen'].
    Akimova EV; Dracheva LV; Gakova EI; Zhuravleva TD; Olfer'ev AM; Gafarov VV; Kuznetsov VA
    Ter Arkh; 2004; 76(1):38-41. PubMed ID: 15108436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-insulin-dependent diabetes mellitus and hyperlipoproteinemia in patients with ischemic cardiopathy].
    Sienra Pérez JC; Cardoso Saldaña G; Ramírez Campos B; Ahumada Ayala M; Posadas Romero C
    Arch Inst Cardiol Mex; 1989; 59(1):35-42. PubMed ID: 2486733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population.
    Binaghi F; Fronteddu PF; Cannas F; Caredda E; Uras A; Garau P; Pitzus F
    Int Angiol; 1994 Sep; 13(3):233-45. PubMed ID: 7822900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The lipoprotein status in persons with borderline glucose tolerance impairment before and after a reducing diet].
    Mirosavljev M; Mirilov M; Bojanović B; Novaković B
    Med Pregl; 1991; 44(11-12):462-6. PubMed ID: 1821443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gemfibrozil in the treatment of hyperlipoproteinemias].
    Monova D; Petrova V; Belovezhdov N
    Vutr Boles; 1991; 30(2):56-8. PubMed ID: 1891900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
    Micheli H; Pometta D; Gustafson A
    Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia].
    Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN
    Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperlipoproteinemias in diabetes mellitus].
    Slavina LS; Romanovskaia GA; Kantordzhan IG; Mazovetskiĭ AG; Riazanovskaia IV
    Probl Endokrinol (Mosk); 1983; 29(3):17-21. PubMed ID: 6866949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The occurence of hyperlipoproteinemia in population of men aged 40--59 years (author's transl)].
    Chotkowska E; Odrowaz-Sypniewska G; Charzewska J; Napierała M; Rywik S; Szostak W; Michalski E
    Przegl Lek; 1978; 35(4-5):460-1. PubMed ID: 693998
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection and characterization of hyperlipoproteinaemia in middle-aged men.
    Hedstrand H; Vessby B
    Ups J Med Sci; 1976; 81(3):159-66. PubMed ID: 1014165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiologic study of atheroscloerosis. ECG--dyslipemia relationship in the estimation of atherogenic risk.
    Mincu I; Cámpeanu S; Dumitrescu C; Mihalache N; Mironescu V; Aron L; Georgescu S; Stănescu I; Boboia D; Bruckner I
    Rev Roum Med Intern; 1973; 10(3):205-18. PubMed ID: 4711376
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyperlipoproteinemia and pancreatitis (author's transl)].
    Löffler A; Löffler-Bock AH; Friedrichs U
    Leber Magen Darm; 1976 Aug; 6(4):249-52. PubMed ID: 1028877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vascular complications in primary hyperlipoproteinemias (HLP) with special reference to changes in the eye fundus].
    Schulze J; Graupner K; Haller H; Hanefeld M; Leonhardt W
    Z Gesamte Inn Med; 1979 May; 34(10):121-2. PubMed ID: 483917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial hyperlipoproteinemia in an isolated part of Newfoundland.
    Anjilvel L
    Can Med Assoc J; 1973 Nov; 109(9):894-5 passim. PubMed ID: 4750306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.